Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at Pinnacle Surgery Center in Austin, Texas, by ...

Down almost 70% from all-time highs, Profound Medical is an undervalued growth stock that offers significant upside potential ...

A world-first study shows stabilised hyaluronic acid gel can safely protect the rectum during radiation therapy for ...

Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.

Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.

This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.

Cardiac magnetic resonance imaging (MRI) is an appropriate non-invasive procedure for functional diagnostics in patients who, ...

Heriot-Watt spin-out Less Grey Imaging is shortlisted for a major health technology award for its AI-driven prostate cancer imaging innovation.

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

On 16 January 2026, Telix Pharmaceuticals announced that the first U.S. patient had been dosed in BiPASS, a Phase 3 trial evaluating Illuccix and Gozellix PSMA-PET imaging alongside MRI for initial ...

A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using stabilized hyaluronic acid (sHA) gel as a rectal spacer during radiation treatment ...

A groundbreaking prostate treatment offering life-changing relief for men has reached Far North Queensland, transforming their quality of life without the risks of traditional surgery. iTIND, known as ...